Medical Management of Women with Symptomatic Uterine Fibroids

[1]  C. Allaire,et al.  The management of uterine leiomyomas. , 2015, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[2]  I. Osterloh,et al.  Ulipristal acetate versus leuprolide acetate for uterine fibroids. , 2012, The New England journal of medicine.

[3]  L. Nieman,et al.  Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. , 2011, Fertility and sterility.

[4]  H. Richter,et al.  Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[5]  C. Muysers,et al.  Levonorgestrel-Releasing Intrauterine System or Medroxyprogesterone for Heavy Menstrual Bleeding: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[6]  K. Stein,et al.  A comprehensive approach to the treatment of uterine leiomyomata. , 2009, The Mount Sinai journal of medicine, New York.

[7]  M. Merino,et al.  The spectrum of endometrial pathology induced by progesterone receptor modulators , 2008, Modern Pathology.

[8]  W. Parker.  Uterine myomas: management. , 2007, Fertility and sterility.

[9]  K. Chwalisz,et al.  A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. , 2007, Fertility and sterility.

[10]  K. Chwalisz,et al.  Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. , 2005, Endocrine reviews.

[11]  C. Farquhar,et al.  An evidence‐based guideline for the management of uterine fibroids , 2001, The Australian & New Zealand journal of obstetrics & gynaecology.

[12]  R. Summitt,et al.  GnRH Agonist and Iron Versus Placebo and Iron in the Anemic Patient Before Surgery for Leiomyomas: A Randomized Controlled Trial , 1995, Obstetrics and gynecology.

[13]  P. Weatherall,et al.  An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. , 1993, The Journal of clinical endocrinology and metabolism.

[14]  R. Shaw,et al.  Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelin , 1989 .